Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01155817
Recruitment Status : Completed
First Posted : July 2, 2010
Last Update Posted : April 15, 2020
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
David Miklos, Stanford University